Adult respiratory distress syndrome (ARDS): current management, future directions.
The adult respiratory distress syndrome, marked by severe, refractory hypoxemia, noncardiogenic pulmonary edema, and stiff, noncompliant lungs, demands quick recognition and intensive care. This article reviews the disease process and current and experimental treatments for it.
Wiedemann
H P
HP
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic, OH 44195, USA.
Tai
D Y
DY
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D006801:Humans; D008875:Middle Aged; D009569:Nitric Oxide / Q000627:therapeutic use; D011379:Prognosis; D011663:Pulmonary Surfactants / Q000627:therapeutic use; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000401:mortality / Q000503:physiopathology* / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D011663:Pulmonary Surfactants; D009569:Nitric Oxide